
New cancer risk tool that flags patients early seeks FDA approval
A new tool that identifies early cancer risk in patients is currently under review with the Food and Drug Administration (FDA), the company that developed the device informed Newsweek, and they hope to have the tool rolled out to Americans next year. C the Signs is a medical device that …


































